Blood test and MRI may end painful bone marrow biopsies for myeloma patients
NCT ID NCT05625971
First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study looked at whether non-invasive methods like a blood test (liquid biopsy) and whole-body MRI can accurately detect leftover cancer cells (minimal residual disease) in people with multiple myeloma. Researchers enrolled 36 newly diagnosed or previously treated patients. The goal is to see if these gentler methods could someday replace the standard bone marrow aspiration and biopsy for many patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New York Presbyterian Hospital/Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.